返回 
加入收藏
全流程药学服务在心血管内科FM35病组患者药品成本管控中的效果分析
x
请在关注微信后，向客服人员索取文件
| 篇名： | 全流程药学服务在心血管内科FM35病组患者药品成本管控中的效果分析 |
| TITLE： | Effects of full-process pharmaceutical services on drug cost control in patients of cardiovascular FM35 disease group |
| 摘要： | 目的 运用全流程药学服务优化心血管内科FM35病组患者药物治疗方案，实现保障患者用药安全并管控住院药品费用的目标。方法以2023年7－8月在我院心血管内科治疗出院的213例FM35病组患者为对照组，筛选其全部医嘱并运用复杂网络分析法及我院药物评价标准制定优化治疗药物库。以2023年9月我院心血管内科新收治入院的83例FM35病组患者为干预组，建立并应用政策宣讲-治疗方案干预的模式，对该组患者进行全流程药学服务。对比两组患者的治疗费用、住院日及出院转归情况。结果通过临床药师全流程药学服务，与对照组比较，干预组患者住院总费用、药品费用、药占比、疾病诊断相关分组（DRG）费用超标病例比例均显著下降（P＜0.05），住院日中位数缩短1d；两组患者的出院转归好转率均≥99%。结论临床药师通过全流程药学服务可在保证医疗质量的基础上有效提升医疗服务效率，节约医疗成本，有效助力DRG的顺利施行。 |
| ABSTRACT： | OBJECTIVE To optimize drug treatment plans for patients in cardiovascular FM35 disease group using full-process pharmaceutical services， and achieve the goals of ensuring patient medication safety and controlling drug costs. METHODS Overall 213 patients in the cardiovascular FM35 disease group who were discharged from July to August 2023 were selected as control group； all medical orders were screened and complex network analysis and drug evaluation standards of our hospital were used to establish an optimized treatment drug library； 83 FM35 patients who newly admitted to the cardiovascular department in September 2023 were selected as intervention group； a model of policy promotion-treatment plan intervention was established and applied to provide full process pharmaceutical services to patients. The treatment cost， length of stay and outcome were analyzed and compared between 2 groups. RESULTS Through the full process pharmaceutical services provided by clinical pharmacists， compared with the control group， the total hospitalization cost， drug cost， drug proportion， and case proportion of medical insurance settlement amount in the intervention group significantly decreased （P＜0.05）. The median length of hospital stay in the intervention group was shortened by 1 d， and the discharge improvement outcome rates of both groups of patients were ≥99%. CONCLUSIONS Clinical pharmacists can effectively improve the efficiency of medical services and save the medical costs through full-process pharmaceutical services， meanwhile ensuring medical quality and safety. This can effectively assist in the smooth implementation of DRGs. |
| 期刊： | 2024年第35卷第17期 |
| 作者： | 曹文静；张鹏；肖灿；刘湘 |
| AUTHORS： | CAO Wenjing，ZHANG Peng，XIAO Can，LIU Xiang |
| 关键字： | 全流程药学服务；疾病诊断相关分组；临床药师；药品成本管控；复杂网络分析法；驻科服务 |
| KEYWORDS： | full process pharmaceutical services； DRG； clinical pharmacist； drug cost control； complex network analysis |
| 阅读数： | 11 次 |
| 本月下载数： | 0 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
